|
|
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
W. Cacheux
,
V. Dangles-Marie
,
E. Rouleau
,
J. Lazartigues
,
E. Girard
et al.
Journal articles
hal-01717339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
C. Bertolotto
,
F. Lesueur
,
S. Giuliano
,
T. Strub
,
Lichy M. De
et al.
Journal articles
hal-01791271v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03623367v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03376715v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
S. Blein
,
Claire Bardel
,
V. Danjean
,
L. Mcguffog
,
S. Healey
et al.
Journal articles
hal-02071165v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|